AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Canopy Growth Corp (NASDAQ:CGC)
1.04 USD
-0.020 1.887%Sponsored Reports
Loading...
| Previous Close (in USD) | 1.06 |
|---|---|
| Change | -0.020 1.887% |
| 52 W H/L (in USD) | 2.380/0.844 |
| EBITDA (in USD) | -8.742M |
| PE Ratio | -- |
| Volume | 5859273 |
| Diluted Eps TTM | -1.35 |
| Total Assets (in USD) | 917.701M |
|---|---|
| Total Liabilities (in USD) | 430.488M |
| Revenue TTM (in USD) | 278.389M |
| Cash (in USD) | 113.811M |
| Market Cap (in USD) | 511.952 M |
| Revenue Per Share TTM | 1.157 |
| Gross Profit TTM (in USD) | 73.944M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Employees: 960
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. David Eric Klein | CEO & Director | 1964 |
| 2. | Ms. Judy Eunjoo Hong | VP of Investor Relations & Competitive Intelligence, Chief of Staff to the CEO and CFO | 1973 |
| 3. | Mr. Julious C. Grant Jr. | Chief Commercial Officer | 1968 |
| 4. | Mr. Jonathan Di Tosto | Chief Operations Officer | NA |
| 5. | Mr. Thomas Carlton Stewart | VP & Chief Accounting Officer | 1982 |
| 6. | Mr. Thomas Shipley IV | Sr. VP of Quality Assurance & Chief Science Officer | 1989 |
| 7. | Dr. Christelle Gedeon L.L.B., Ph.D. | Chief Legal Officer | 1982 |
| 8. | Mr. Timothy Rob Saunders F.C.A., FCPA | Strategic Advisor | 1961 |
| 9. | Jason Green | Head of Agriculture - Hemp Division | NA |
| 10. | Dr. Mark A. Ware | Chief Medical Officer | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
+1.200 1.571% | 76.22 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
+0.580 1.906% | 30.72 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
0.000 0.000% | 153.91 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
GALDY
GALDERMA GROUP AG |
-0.790 1.894% | 41.335 | 74.210 | 41.667 | 8.636 | 5.553 | 9.151 | 42.220 |
Income Statement
(Currency in USD)| Breakdown | 31-03-2025 | 31-03-2024 | 31-03-2023 | 31-03-2022 | 31-03-2021 |
|---|---|---|---|---|---|
| Income Before Tax | -596.997M | -471.355M | -3314.32M | -329.433M | -1683.961M |
| Minority Interest | 0M | 18.526M | 31.388M | 18.304M | 140.009M |
| Net Income | -598.115M | -657.269M | -3309.546M | -320.485M | -1670.82M |
| Selling General Administrative | 60.855M | 104.445M | 487.413M | 520.281M | 666.538M |
| Gross Profit | 79.511M | 80.882M | -104.14M | -193.054M | 66.96M |
| Reconciled Depreciation | 43.118M | 53.176M | 84.517M | 114.418M | 127.118M |
| Ebit | -522.428M | -366.003M | 1665.189M | -1082.674M | 44.3M |
| Ebitda | -479.31M | -312.827M | 1749.706M | -229.578M | 171.418M |
| Depreciation And Amortization | 43.118M | 53.176M | 84.517M | 853.096M | 127.118M |
| Operating Income | -117.143M | -228.714M | 1665.189M | -1082.674M | 44.3M |
| Other Operating Expenses | 386.138M | 525.86M | 994.457M | 1233.66M | 1146.227M |
| Interest Expense | 74.569M | 105.352M | 126.16M | 103.944M | 8.459M |
| Tax Provision | 7.141M | 12.327M | -4.774M | -8.948M | -13.141M |
| Interest Income | 8.815M | 16.235M | 24.282M | 6.601M | 21.367M |
| Net Interest Income | -65.754M | -89.117M | -101.878M | -97.343M | 12.908M |
| Income Tax Expense | 7.141M | 12.327M | -4.774M | -8.948M | -13.141M |
| Total Revenue | 268.995M | 297.146M | 402.904M | 520.325M | 546.649M |
| Total Operating Expenses | 196.654M | 309.596M | 487.413M | 520.281M | 666.538M |
| Cost Of Revenue | 189.484M | 216.264M | 507.044M | 713.379M | 479.689M |
| Total Other Income Expense Net | -479.854M | -242.641M | -4979.509M | 753.241M | -1728.261M |
| Net Income From Continuing Ops | -604.138M | -483.682M | -3309.546M | -320.485M | -1670.82M |
| Net Income Applicable To Common Shares | - | - | - | -302.181M | -1744.92M |
Balance Sheet
(Currency in USD)| Breakdown | 31-03-2025 | 31-03-2024 | 31-03-2023 | 31-03-2022 | 31-03-2021 |
|---|---|---|---|---|---|
| Total Assets | 917.701M | 1300.33M | 2439.098M | 5615.05M | 6823.48M |
| Intangible Assets | 87.2M | 104.053M | 188.719M | 252.695M | 308.167M |
| Other Current Assets | 13.954M | 45.484M | 10.115M | 19.065M | 67.232M |
| Total Liab | 430.488M | 799.823M | 1679.076M | 1984.553M | 3201.66M |
| Total Stockholder Equity | 487.213M | 500.368M | 758.435M | 3589.956M | 3481.811M |
| Other Current Liab | 34.432M | 70.566M | 94.727M | 139.332M | 106.428M |
| Common Stock | 8796.406M | 8244.301M | 7938.571M | 7482.809M | 7168.557M |
| Capital Stock | 8796.406M | 8244.301M | 7938.571M | 7482.809M | 7168.557M |
| Retained Earnings | -10928.145M | -10330.03M | -9672.761M | -6370.337M | -6068.156M |
| Good Will | 46.042M | 43.239M | 85.563M | 1866.503M | 1889.354M |
| Other Assets | - | 0M | - | 15.342M | 4.961M |
| Cash | 113.811M | 170.3M | 677.007M | 776.005M | 1154.653M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 94.404M | 234.715M | 803.842M | 212.898M | 284.33M |
| Current Deferred Revenue | - | 5.849M | 75.991M | - | 100.813M |
| Net Debt | 234.586M | 497.699M | 629.874M | 724.986M | 428.31M |
| Short Term Debt | 20.8M | 119.108M | 556.89M | 9.296M | 9.827M |
| Short Long Term Debt | 4.258M | 103.935M | 556.89M | 9.296M | 9.827M |
| Short Long Term Debt Total | 348.397M | 667.999M | 1306.881M | 1500.991M | 1582.963M |
| Other Stockholder Equity | 2618.417M | 2602.148M | -7166.276M | 2519.766M | 2415.65M |
| Property Plant Equipment | - | - | - | 942.78M | 1074.537M |
| Total Current Assets | 294.574M | 371.18M | 1077.254M | 1737.402M | 2838.194M |
| Long Term Investments | 35.294M | 136.221M | 568.292M | 341.733M | 708.267M |
| Short Term Investments | 17.656M | 33.161M | 105.595M | 595.651M | 1144.563M |
| Net Receivables | 52.78M | 44.943M | 93.987M | 96.443M | 92.435M |
| Long Term Debt | 299.811M | 493.294M | 749.991M | 1491.695M | 1573.136M |
| Inventory | 96.373M | 77.292M | 148.901M | 204.387M | 367.979M |
| Accounts Payable | 26.099M | 28.673M | 76.234M | 64.27M | 67.262M |
| Accumulated Other Comprehensive Income | 0.535M | -16.051M | -13.86M | -42.282M | -34.24M |
| Non Currrent Assets Other | 161.068M | 325.534M | 19.447M | -0.649M | -16.418M |
| Non Current Assets Total | 623.127M | 929.15M | 1361.844M | 3877.648M | 3985.286M |
| Capital Lease Obligations | 44.328M | 70.77M | 109.309M | 139.16M | 136.225M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-03-2025 | 31-03-2024 | 31-03-2023 | 31-03-2022 | 31-03-2021 |
|---|---|---|---|---|---|
| Investments | -47.788M | 241.59M | 433.379M | 166.577M | -497.555M |
| Total Cashflows From Investing Activities | -47.788M | 241.59M | - | 230.819M | -884.105M |
| Total Cash From Financing Activities | 148.66M | -465.055M | -19.694M | -45.533M | 1264.769M |
| Net Income | -604.138M | -483.682M | -3309.546M | -320.485M | -1670.82M |
| Change In Cash | -56.489M | -506.707M | -98.998M | -378.648M | -148.523M |
| Begin Period Cash Flow | 170.3M | 677.007M | 776.005M | 1154.653M | 1303.176M |
| End Period Cash Flow | 113.811M | 170.3M | 677.007M | 776.005M | 1154.653M |
| Total Cash From Operating Activities | -165.75M | -281.95M | -557.546M | -545.811M | -465.729M |
| Depreciation | 43.118M | 53.176M | 84.517M | 114.418M | 127.118M |
| Other Cashflows From Investing Activities | 48.9M | 167.792M | - | -18.126M | -66.746M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | -17.715M | 1.034M | 55.638M | 173.189M | 17.211M |
| Sale Purchase Of Stock | - | - | - | - | - |
| Other Cashflows From Financing Activities | -15.955M | -36.339M | 97.436M | 2.53M | 1279.008M |
| Capital Expenditures | 11.28M | 3.996M | 10.554M | 48.113M | 174.141M |
| Change In Working Capital | -31.965M | 3.967M | 65.845M | 165.558M | -4.333M |
| Other Non Cash Items | 424.299M | 118.082M | 2575.224M | -543.879M | 1004.298M |
| Free Cash Flow | -177.03M | -285.946M | -568.1M | -593.924M | -639.87M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | LVIP Dimensional Intl Core Eq Std | 5 months ago | 7038 |
| 2. | Arca Azioni Internazionali P | 2 months ago | 367 |
| 3. | Global FML Fund R | 2 months ago | 304 |
| 4. | AZL® DFA International Core Equity | 5 months ago | 90 |
| 5. | RiverPark Strategic Income Institutional | 2 months ago | 16211500 |
| 6. | ETFMG Alternative Harvest ETF | 2 months ago | 8479893 |
| 7. | Global X Marijuana Life Sciences ETF | 2 months ago | 2918408 |
| 8. | TD Canadian Equity Index ETF | 2 months ago | 394970 |
| 9. | Mackenzie Canadian Equity ETF | 2 months ago | 347994 |
| 10. | iShares S&P/TSX Small Cap ETF | 2 months ago | 293140 |
| 11. | AdvisorShares Pure Cannabis ETF | 2 months ago | 289683 |
| 12. | CANSOUL Fonds Hanf Aktien Global EUR C | 3 months ago | 270000 |
| 13. | State Street® SPDR® S&P® Intl Sm Cp ETF | 2 months ago | 136701 |
| 14. | Desjardins Canadian Equity Index ETF | 2 months ago | 118753 |
| 15. | TD Canadian Index - I | 5 months ago | 112253 |
| 16. | USA Mutuals Vice Investor | 5 months ago | 100000 |
| 17. | Lazard US Systematic Small Cap Eq ETF | 2 months ago | 99915 |
| 18. | Scotia Canadian Equity Index A | 5 months ago | 71618 |
| 19. | State Street® SPDR® Ptf Dev Wld exUS ETF | 2 months ago | 21415 |
| 20. | CI Canadian Equity ETF | 2 months ago | 18937 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Jane Street Group LLC | 5 months ago | 7426723 |
| 2. | Tidal Investments LLC. | 5 months ago | 6747095 |
| 3. | Susquehanna International Group, LLP | 5 months ago | 5143556 |
| 4. | Caitong International Asset Management Co., Limited. | 5 months ago | 4595330 |
| 5. | D. E. Shaw & Co LP | 5 months ago | 4233630 |
| 6. | Citadel Advisors Llc | 5 months ago | 2031319 |
| 7. | Morgan Stanley - Brokerage Accounts | 8 months ago | 1676253 |
| 8. | Headlands Technologies LLC | 5 months ago | 987809 |
| 9. | The Goldman Sachs Group Inc | 5 months ago | 780357 |
| 10. | Sullivan Wood Capital Management, LLC | 5 months ago | 772785 |
| 11. | NATIONAL BANK OF CANADA /FI/ | 8 months ago | 721866 |
| 12. | Millennium Management LLC | 5 months ago | 704356 |
| 13. | UBS Group AG | 8 months ago | 575107 |
| 14. | SBI Securities Co Ltd | 5 months ago | 545311 |
| 15. | SIMPLEX TRADING, LLC | 5 months ago | 487670 |
| 16. | SIG North Trading, ULC | 5 months ago | 465493 |
| 17. | Royal Bank of Canada | 8 months ago | 444697 |
| 18. | Foundations Investment Advisors, LLC | 5 months ago | 425036 |
| 19. | SLT Holdings LLC | 5 months ago | 425000 |
| 20. | TD Asset Management Inc | 5 months ago | 422859 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...